myAirvo 2

Humidified high flow therapy system
Deliver humidified high flows from 2-60 L/min to chronic respiratory patients at home or in long-term care facilities.

Product enquiry
Learn how myAirvo™ 2 can help patients manage chronic respiratory conditions

Humidified high flow therapy has been shown to ease symptoms such as frequent coughs and breathlessness as well as reduce escalation of care in patients with conditions such as COPD.1-4 The myAirvo 2 is an innovative humidified high flow system that delivers the therapy through an Optiflow™ nasal cannula and a trio of advanced technologies.
myAirvo 2 Introduction
Discover the myAirvo 2 technology
Advanced humidity algorithm
The myAirvo 2 algorithm’s intelligent controls deliver Optimal Humidity to patients at 37, 34 or 31 °C.
myAirvo 2 air pathway
A uniquely designed air pathway thoroughly conditions the mix of air and oxygen to accurately deliver the patient’s set flow rate.
AirSpiral™ Tube
The two-spiral design produces up to 93% less condensate*, maximizing humidity levels of the breathing gas.
*When compared with Airvo tube 900PT501 in internal F&P testing
Choose between two myAirvo 2 setups
Enquire about myAirvo
If you have an enquiry about our products, please provide the following information so a Fisher & Paykel Healthcare representative can contact you. For further details on how this information will be used, see below or go to our privacy statement.
I consent to Fisher & Paykel Healthcare keeping me informed about new F&P products, clinical updates, events and promotions on the following topics:

Enter security code:*
 Security code
F&P, myAirvo, Airvo, AirSpiral and Optiflow are trademarks of Fisher & Paykel Healthcare Limited. For patent information, see